STONY BROOK, NY--(Marketwire - May 14, 2009) -
Highlighted Links |
APDN Website |
APDN Docs and Packaging |
SigNature DNA is derived from botanical plant sources, and is similar to a set of blueprints, or a specific code, that has been developed for compatibility, stability and recoverability in cyanoacrylate. Previously tested in a range of glues and label adhesives, SigNature DNA has shown to be persistent in the glue itself, as well as when the adhesive is applied onto a substrate like a label.
Very "Sticky" and Versatile
SigNature DNA-cyanoacrylate can be applied to virtually any item surface or even absorbed into porous and semi-porous materials like ceramics, as well as non-porous materials like metal, glass and plastic.
Setting a Forensic Evidence Trail
Cyanoacrylate is frequently used as a forensic tool to capture latent fingerprints on non-porous surfaces such as glass or plastic. Despite its commercial ubiquity and use in crime labs, until now, cyanoacrylate solutions have rarely been used for security marking and authentication purposes.
Together, SigNature DNA-cyanoacrylate provides a powerful system that can be used to link DNA-marked evidence at a crime scene to the criminal. It's the ultimate tool to ensure the safety of a wide range of electronic and electrical components, often used in products ranging from laptops and mobile phones to motor vehicles and aircraft. By incorporating SigNature DNA-cyanoacrylate into the existing manufacturing process, any product or package can be further securitized with a forensic layer of anti-counterfeiting protection.
About APDN
APDN sells patented DNA security solutions to protect products, brands and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used to authenticate products in a unique manner that essentially cannot be copied. APDN also provides BioMaterial GenoTyping™ by detecting genomic DNA in natural materials to authenticate finished products. Both technologies protect brands and products in a wide range of industries and provide a forensic chain of evidence that can be used to prosecute perpetrators. To learn more, go to (www.adnas.com).
The statements made by APDN may be forward-looking in nature and are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements describe APDN's future
plans, projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many of which
are beyond the control of APDN. Actual results could differ materially from
those projected due to our short operating history, limited financial
resources, limited market acceptance, market competition and various other
factors detailed from time to time in APDN's SEC reports and filings,
including our Annual Report on Form 10-K, filed on December 16, 2008 and
our subsequent quarterly reports on Form 10-Q. APDN undertakes no
obligation to update publicly any forward-looking statements to reflect new
information, events or circumstances after the date hereof to reflect the
occurrence of unanticipated events.
INVESTOR CONTACT:
Debbie Bailey
631-444-8090
fax: 631-444-8848
MEDIA CONTACT:
Janice Meraglia
631-444-6293
fax: 631-444-8848
FCMN Contact: Email Contact
Web site: http://www.adnas.com